SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is facing significant downward pressure following a launch anomaly where Blue Origin's New Glenn rocket failed to place a BlueBird satellite into the correct orbit. While the community is actively debating the impact of this setback on launch timelines and partner reliability, investors are divided between capitalizing on the dip as an overreaction to an insured event and concerns regarding execution risks versus established industry competitors.

Newcourt Acquisition Corp. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on February 25, 2021 and is headquartered in Oakland, CA.

Psyence Biomedical Ltd.

Psyence Biomedical is experiencing massive social media buzz following an executive order that fast-tracks research for psychedelic therapies, with the community highlighting its focus on Ibogaine as a primary catalyst. Investors are actively debating the stock's potential for a short squeeze due to its low float and limited share availability, as strong sentiment clashes with warnings about the inherent volatility of micro-cap biotech trading.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth is trending as investors react to a strategic $2.8 billion acquisition of Brazil's Serra Verde Group, a move designed to secure critical supply chain independence for magnetic rare earths. While the community is actively debating the short-term impact of the stock-and-cash dilution, broader sentiment remains focused on the company's long-term potential as a U.S.-backed infrastructure play for the defense, EV, and AI sectors.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe is facing intense market volatility as investors weigh the potential of its AI-driven enterprise tools against fears that generative AI could disrupt its established creative software moat. The stock is currently experiencing significant downward pressure as the community debates whether the recent sell-off represents an irrational disconnect from elite fundamentals or a structural shift in the software landscape.

Atai Beckley, Inc. is a clinical-stage biopharmaceutical company focused on developing effective, rapid-acting, and convenient mental health treatments. The company is headquartered in New York, NY.

AtaiBeckley Inc.

ATAI Life Sciences N.V.

ATAI Life Sciences is trending due to positive developments, including Breakthrough Therapy designation for their depression drug and influential endorsements. The community is discussing the potential for upcoming Phase 3 trials and the impact of AdvisorShares podcast featuring Christian Angermayer. Shareholder discussions also address recent stock offerings and their effect on price movements.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. It operates through the Steelmaking and Other Businesses segments. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs is currently a focal point for investors as the community debates the impact of potential trade enforcement, ongoing industry consolidation rumors, and the CEO's recent strategic maneuvers. While some market participants are optimistic about the company's vertically integrated position and the long-term potential for a POSCO partnership, others are expressing significant caution regarding the company's debt levels and recent insider selling activity.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is trending as investors focus on its potential as a breakthrough in cancer immunotherapy, bolstered by positive clinical trial data and recent analyst coverage projecting significant peak sales. The community is actively debating the company's valuation relative to its pipeline, with bullish sentiment driven by anticipation of upcoming prostate cancer data reveals and the possibility of strategic partnerships or buyout interest.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

COMPASS Pathways (CMPS) and peers in the psychedelic biotech space are surging following an executive order from President Trump designed to accelerate research and FDA review pathways for mental health treatments. While the sector is experiencing high-conviction momentum and institutional interest, community discourse remains divided between those betting on long-term clinical success and those wary of volatility and the potential for short-term speculative 'pump and dump' dynamics.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Life Sciences is gaining momentum as retail investors and the community ramp up activity ahead of the upcoming AACR conference, where new data for the SLS009 platform will be presented. Supporters are actively discussing the potential for a significant price movement driven by heavy call option positioning and large-scale short interest, while long-term investors remain focused on the clinical potential of the GPS pivotal Phase 3 study.

Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also focuses on immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective medicines with optimal therapeutic benefit. The company was founded in 1990 and is headquartered in San Francisco, CA.

Nektar Therapeutics

Nektar Therapeutics is gaining significant market attention as traders position for imminent Phase 2b data from its alopecia areata trial, a catalyst that follows a period of positive momentum in its broader autoimmune pipeline. While some community members voice concerns over potential volatility and past management execution, the bullish sentiment remains anchored in the drug's differentiated mechanism of action and the anticipation of a potential settlement or partnership deal involving Eli Lilly.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


digirater7

Digirater